G Chaplain
Overview
Explore the profile of G Chaplain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gentil-Brevet J, Colonna M, Danzon A, Grosclaude P, Chaplain G, Velten M, et al.
Br J Cancer
. 2008 Jan;
98(1):217-24.
PMID: 18182980
Survival data on female invasive breast cancer with 9-year follow-up from five French cancer registries were analysed by logistic regression for prognostic factors of cancer stage. The Kaplan-Meier method and...
2.
Dabakuyo T, Bonnetain F, Roignot P, Poillot M, Chaplain G, Altwegg T, et al.
Ann Oncol
. 2007 Oct;
19(2):276-83.
PMID: 17962200
Background: Few population-based studies have reported jointly analyses of relative survival according to the following prognostic factors: tumour-node-metastasis (TNM) stage, age, number of examined and positive nodes, hormonal status, histological...
3.
Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh J, et al.
Br J Cancer
. 2004 Sep;
91(7):1263-8.
PMID: 15365566
We analysed the 5-year relative survival among 4473 breast cancer cases diagnosed in 1990-1992 from cancer registries in Estonia, France, Italy, Spain, the Netherlands and the UK. Among eight categories...
4.
Chaplain G, Quantin C, Mottot C, Michiels-Marzais D, Sasco A
Cancer Detect Prev
. 2001 Mar;
25(1):40-7.
PMID: 11270420
Our objectives were to evaluate the effectiveness of cervical cancer screening outside organized programs in the prevention of cervical carcinoma in situ (CIS) and to enhance the way in which...
5.
Barillot I, Horiot J, Maingon P, Truc G, Chaplain G, Comte J, et al.
Int J Radiat Oncol Biol Phys
. 2000 Aug;
48(1):189-200.
PMID: 10924989
Purpose: The aim of the study was to determine the predictive factors of complications, to evaluate the impact of customized treatment planning on late normal tissue effects per stage, and...
6.
Chaplain G, Milan C, Sgro C, Carli P, Bonithon-Kopp C
J Clin Oncol
. 2000 Aug;
18(15):2836-42.
PMID: 10920131
Purpose: To quantify the risk of acute leukemia after adjuvant therapy, especially chemotherapy with topoisomerase II inhibitors. Patients And Methods: We performed a population-based study in a cohort of 3,093...
7.
Colonna M, Hedelin G, Esteve J, Grosclaude P, Launoy G, Buemi A, et al.
Int J Cancer
. 2000 Jun;
87(2):301-4.
PMID: 10861491
In France, as in several other European countries, prevalence has to be estimated from the modelling of 2 of the 3 basic epidemiological measures of incidence, mortality, and survival. Since,...
8.
Chaplain G, Coudert B, Milan C, Altwegg T, Esteve J
Bull Cancer
. 1999 Nov;
86(10):855-60.
PMID: 10572236
Using the 2,208 non metastatic breast cancer diagnosed women who underwent breast surgery from the 2,432 first breast cancers recorded by the French département of Côte-d'Or cancer registry from 1982...
9.
Colonna M, Grosclaude P, Faivre J, Revzani A, Arveux P, Chaplain G, et al.
J Epidemiol Community Health
. 1999 Nov;
53(9):558-64.
PMID: 10562880
Study Objective: In many countries, cancer registries cover only a small part of the national population. Cancer incidence for the rest of the country has therefore to be estimated. This...
10.
Marchal C, Weber B, de Lafontan B, Resbeut M, Mignotte H, du Chatelard P, et al.
Int J Radiat Oncol Biol Phys
. 1999 Apr;
44(1):113-9.
PMID: 10219803
Objectives: To conduct a survey of the angiosarcomas developing after breast conservation for carcinoma in the French Cancer Centers, to study the evolution of these cases in detail, and to...